Options Brief: Regeneron Pharmaceuticals, Inc. (REGN)

Shares of Regeneron Pharmaceuticals, Inc. REGN are higher on the session by 0.52%, trading at $49.94. Overall put volume is now running at 3.14x the daily average, with 30% of all puts traded being purchases on the offer. 1,320 contracts have traded on the session so far. Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company. Regeneron discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions.